Trilaciclib dihydrochloride is a pharmaceutical raw material used to reduce the frequency of chemotherapy-induced bone marrow suppression. It is a salt-form compound with a complex heterocyclic structure containing multiple amine and amide functional groups.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1977495-97-8
Trilaciclib
pharmaceutical raw material
(2S)-4-Amino-N-{(1R,2S,5S)-5-amino-4-[(6-amino-6-deoxy-alpha-D-glycero-hexopyranosyl)oxy]-2-[(3-{[(2S)-4-amino-2-hydroxybutanoyl]amino}-3-deoxy-alpha-D-threo-hexopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanamide
pharmaceutical raw material
Teduglutide
pharmaceutical raw material
3-[(3R,4S)-3,4-dimethylpiperidin-4-yl]phenol
pharmaceutical raw material
Picloxydine dihydrochloride
pharmaceutical raw material
4-[[5-(4-methylpiperazin-1-yl)-2-pyridinyl]amino]spiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-10-one;dihydrochloride
BRCYOXKEDFAUSA-UHFFFAOYSA-N
CN1CCN(CC1)C2=CN=C(C=C2)NC3=NC=C4C=C5C(=O)NCC6(N5C4=N3)CCCCC6.Cl.Cl